ArticleNature communications2024

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen.

Natasha Strydom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.